United States · FDA National Drug Code directory
Nystatin
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0121-0868_7d265612-edc5-42bc-8e58-bae7d7ab7918
- Product NDC
- 0121-0868
- Form
- SUSPENSION
- Composition / generic term
- NYSTATIN
- Labeler
- PAI Holdings, LLC dba PAI Pharma
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20200717
- Source listing expiry
- 20271231
Source-listed ingredients
- NYSTATIN — 100000 [USP'U]/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 10 TRAY in 1 CASE (0121-0868-00) / 10 CUP, UNIT-DOSE in 1 TRAY / 5 mL in 1 CUP, UNIT-DOSE (0121-0868-05) · 0121-0868-00
- 60 mL in 1 BOTTLE, DROPPER (0121-0868-02) · 0121-0868-02
- 473 mL in 1 BOTTLE (0121-0868-16) · 0121-0868-16
- 5 TRAY in 1 CASE (0121-0868-50) / 10 CUP, UNIT-DOSE in 1 TRAY / 5 mL in 1 CUP, UNIT-DOSE (0121-0868-05) · 0121-0868-50
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →